Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Times Interest Earned: 2023-2025

Historic Times Interest Earned for Arcus Biosciences (RCUS) over the last 2 years, with Sep 2025 value amounting to -$47.33.

  • Arcus Biosciences' Times Interest Earned rose 54.92% to -$47.33 in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.88, marking a year-over-year change of. This contributed to the annual value of -$82.50 for FY2024, which is 51.47% up from last year.
  • Latest data reveals that Arcus Biosciences reported Times Interest Earned of -$47.33 as of Q3 2025, which was down 1,083.33% from -$4 recorded in Q2 2025.
  • Arcus Biosciences' Times Interest Earned's 5-year high stood at -$4 during Q2 2025, with a 5-year trough of -$122 in Q1 2025.
  • For the 3-year period, Arcus Biosciences' Times Interest Earned averaged around -$60.83, with its median value being -$51.50 (2024).
  • Within the past 5 years, the most significant YoY rise in Arcus Biosciences' Times Interest Earned was 54.92% (2025), while the steepest drop was 662.50% (2025).
  • Arcus Biosciences' Times Interest Earned (Quarterly) stood at -$80 in 2023, then plummeted by 31.25% to -$51.50 in 2024, then spiked by 54.92% to -$47.33 in 2025.
  • Its Times Interest Earned stands at -$47.33 for Q3 2025, versus -$4 for Q2 2025 and -$122 for Q1 2025.